Acute Respiratory Distress Syndrome News and Research

RSS
What factors are associated with readmission in pediatric survivors of acute respiratory distress syndrome (ARDS)?

What factors are associated with readmission in pediatric survivors of acute respiratory distress syndrome (ARDS)?

New ARDS definition could expand diagnosis and treatment options

New ARDS definition could expand diagnosis and treatment options

Mutational changes in Avian flu virus could increase risk of transmission to humans

Mutational changes in Avian flu virus could increase risk of transmission to humans

Study investigates the pathophysiological mechanisms of PASC after COVID-19

Study investigates the pathophysiological mechanisms of PASC after COVID-19

Obese adults with ARDS may benefit from ECMO

Obese adults with ARDS may benefit from ECMO

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Revolutionizing COVID-19 ARDS prediction: a deep learning model for critically ill patients

Revolutionizing COVID-19 ARDS prediction: a deep learning model for critically ill patients

The impact of diabetes mellitus on morbidity and mortality in patients with COVID-19

The impact of diabetes mellitus on morbidity and mortality in patients with COVID-19

Study shows that COVID-19 patients presented different plasma trace elements levels depending on disease severity

Study shows that COVID-19 patients presented different plasma trace elements levels depending on disease severity

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

COVID-19 severity linked to autoantibodies against blood clotting protein

COVID-19 severity linked to autoantibodies against blood clotting protein

Therapeutic nanocarriers engineered from adult skin cells show promise for treating lung injury

Therapeutic nanocarriers engineered from adult skin cells show promise for treating lung injury

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Unlocking the brain-lung dialogue key to future treatments for critical care patients

Unlocking the brain-lung dialogue key to future treatments for critical care patients

Comparing clinical characteristics and outcomes of critically ill COVID-19 patients with a chohort admitted to ICU for influenza pneumonia

Comparing clinical characteristics and outcomes of critically ill COVID-19 patients with a chohort admitted to ICU for influenza pneumonia

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.